MedPath

To estimate the water loss through the epidermis and a scale called Eczema area and severity index to compare the efficacy of two topical medications called crisaborole 2% and tacrolimus 0.1% in patients with mild to moderate atopic dermatitis.

Not Applicable
Conditions
Health Condition 1: L209- Atopic dermatitis, unspecified
Registration Number
CTRI/2024/05/067254
Lead Sponsor
Dr Aisha Salim
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with AD willing to participate and those with age 16 and more with the diagnosis of mild to moderate Atopic dermatitis on the basis of Hannifin and Rajka criteria.

Exclusion Criteria

1.Patient on topical and systemic corticosteroid, Immunosuppressants , UVA and UVB therapy .

2.Patients with atopic dermatitis having other skin diseases.

3.Pregnant and lactating women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath